Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Psoriatic Arthritis, a Management Review

  |  

As part of the Review Course on Friday Nov. 15 at ACR Convergence 2024, Ana-Maria Orbai, MD, MHS, associate professor of medicine and director of the Psoriatic Arthritis Program at the Johns Hopkins School of Medicine, will present a session reviewing the management of psoriatic arthritis.

Dr. Orbai

Dr. Orbai

Dr. Orbai earned her medical degree from the Iuliu Hatieganu School of Medicine and Pharmacy, Cluj-Napoca, in Romania. She then completed internship and residency training in Internal Medicine at the Johns Hopkins University-Sinai Hospital program. Subsequently, Dr. Orbai pursued fellowship training in rheumatology at the Johns Hopkins University School of Medicine.

ADVERTISEMENT
SCROLL TO CONTINUE

She joined the Johns Hopkins Arthritis Center and is actively involved in patient care, with a predominant focus on psoriatic arthritis and rheumatoid arthritis. Her research efforts seek to understand, from patients, how they experience arthritis in their lives. This knowledge will build the foundation for choosing and designing measures of disease activity and health-related quality of life measures that can be used to improve the care and outcomes of people with arthritis.

Following ACR Convergence, watch this space for details on Dr. Orbai’s presentation at ACR Convergence 2024.

ADVERTISEMENT
SCROLL TO CONTINUE

Related Articles

    The Management of Psoriatic Arthritis: A Review

    WASHINGTON, D.C.—As of November 2024, there are 16 biologic disease-modifying anti-rheumatic drugs (bDMARDs) that are FDA approved for the treatment of psoriatic arthritis (PsA). Incredible news, right? But as my fellowship program director used to say, “There’s no free lunch.” This buffet of options is excellent for our patients, but poses challenges to the practicing…

    The 2019 ACR Award Winners & Distinguished Fellows

    ATLANTA—Every year at its Annual Meeting, the ACR recognizes its members’ outstanding contributions to the field of rheumatology through an awards program. The ACR is proud to announce 20 award recipients for 2019, honored for their accomplishments as clinicians, instructors or researchers who have helped advance rheumatology, for their commitment to inspire others to enter…

    Case Report: A Psoriatic Arthritis Patient with Dactylitis & Enthesitis

    A 36-year-old woman presented at the Johns Hopkins Arthritis Center for a second opinion regarding a diagnosis of psoriatic arthritis (PsA). One year prior to our evaluation, she had developed pain and stiffness in her hands, feet, knees, ankles, elbows and shoulders. She had mild plaque psoriasis of the scalp and base of the neck,…

    The 2021 ACR Awards of Distinction & Distinguished Fellows

    During ACR Convergence 2021 in early November, the ACR honored a group of individuals who have made significant contributions to rheumatology research, education and patient care, announcing the recipients of the ACR’s 2021 Awards of Distinction, as well as the group of Distinguished Fellows. recognized for their contributions. Three pediatric rheumatologists and one pediatric fellow…